Literature DB >> 35088351

Transcriptomic analysis of functional diversity of human umbilical cord blood hematopoietic stem/progenitor cells in erythroid differentiation.

Svetlana Soboleva1, Hugo Åkerstrand2, Kenichi Miharada3,4.   

Abstract

Hematopoietic stem cells (HSC) give rise to all types of blood lineages, including red blood cells (RBC). Hematopoietic stem/progenitor cells (HSPC) are known to be functionally diverse in terms of their self-renewal potential and lineage output. Consequently, investigation of molecular heterogeneity in the differentiation potential of HSPC is vital to identify novel regulators that affect generation of specific cell types, especially RBC. Here, we compared the erythroid potential of CD34+ hematopoietic stem and progenitor cells from 50 different umbilical cord blood (UCB) donors and discovered that those donors gave rise to diverse frequencies of Glycophorin-A+ erythroid cells after in vitro differentiation, despite having similar frequencies of phenotypic HSC initially. RNA sequencing revealed that genes involved in G protein-coupled receptor (GPCR) signaling were significantly up-regulated in the high-erythroid output donors. When we chemically modified two main signaling elements in this pathway, adenylyl cyclase (AC) and phosphodiesterase (PDE), we observed that inhibition of PDE led to 10 times higher yield of Glycophorin-A+ cells than activation of AC. Our findings suggest that GPCR signaling, and particularly the cAMP-related pathway, contributes to the diversity of erythroid potential among UCB donors.
© 2022. Japanese Society of Hematology.

Entities:  

Keywords:  AKAP; Erythropoiesis; Stem cell heterogeneity; Umbilical cord blood; cAMP

Mesh:

Substances:

Year:  2022        PMID: 35088351     DOI: 10.1007/s12185-022-03292-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  1 in total

1.  Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells.

Authors:  G D'Arena; P Musto; N Cascavilla; G Di Giorgio; F Zendoli; M Carotenuto
Journal:  Haematologica       Date:  1996 Sep-Oct       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.